Related Experiment Video
Updated: Nov 29, 2025

10:49
Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
9.1K
Maternal antibody interference contributes to reduced rotavirus vaccine efficacy in developing countries
Claire E Otero1,2, Stephanie N Langel1,3, Maria Blasi1,4
1Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Plos Pathogens
|November 19, 2020
Summary
Maternal antibodies reduce rotavirus (RV) vaccine effectiveness in infants in lower-income countries. Further research, including animal models, is needed to understand and overcome this interference for better infant immunization.
Area of Science:
- Immunology
- Vaccinology
- Global Health
Background:
- Rotavirus (RV) vaccine efficacy is lower in lower- and middle-income countries (LMICs) compared to high-income countries.
- Maternal antibodies (matAbs), transferred via placenta and breast milk, may interfere with infant immune responses to oral RV vaccines.
Purpose of the Study:
- To review current research on mechanisms reducing RV vaccine efficacy in LMICs.
- To focus on the role of maternal antibody interference in this disparity.
Main Methods:
- Review of observational studies and existing literature on RV vaccine responses in infants.
- Analysis of the potential impact of maternal immunoglobulin G (IgG) and IgA on vaccine-induced immunity.
Main Results:
- Observational studies show an inverse correlation between maternal antibody titers and infant responses to RV vaccination in LMICs.
- A definitive causal link and the specific mechanisms of interference remain to be established, partly due to limitations in animal models.
Conclusions:
- Maternal antibody interference is a plausible factor contributing to reduced RV vaccine efficacy in LMICs.
- Development of better animal models is crucial for understanding interference mechanisms and designing effective interventions or alternative vaccine strategies.
Related Concept Videos
Development of Immunocompetence
599
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
599
Vaccinations
49.6K
Overview
49.6K
Cross-reactivity
32.3K
Overview
32.3K

